Table of Contents
Empagliflozin is a medication used primarily to treat type 2 diabetes. It belongs to a class of drugs called SGLT2 inhibitors, which help lower blood glucose levels.
What is Empagliflozin?
Empagliflozin works by blocking the sodium-glucose co-transporter 2 (SGLT2) in the kidneys. This transporter is responsible for reabsorbing glucose from urine back into the bloodstream.
How Does It Lower Blood Glucose?
By inhibiting SGLT2, empagliflozin prevents glucose reabsorption. This causes excess glucose to be excreted in the urine, reducing blood glucose levels.
Mechanism of Action
The drug binds to the SGLT2 proteins in the proximal tubules of the kidneys. This blockade decreases glucose reabsorption, leading to increased urinary glucose excretion. Consequently, blood sugar levels decline, helping to manage hyperglycemia.
Additional Benefits
- Reduces blood pressure
- Promotes weight loss
- Decreases risk of cardiovascular events in some patients
Potential Side Effects
- Urinary tract infections
- Genital yeast infections
- Dehydration and low blood pressure
Patients should consult their healthcare provider to determine if empagliflozin is appropriate for their condition and to discuss potential side effects.